Successful treatment of atopic diseases with allergoids tyrosin S and oralvac

N. Mojsoski (Skopje, Fyrom)

Source: Annual Congress 2001 - Novel approaches to treatment of lung disease
Session: Novel approaches to treatment of lung disease
Session type: Thematic Poster Session
Number: 2896
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Mojsoski (Skopje, Fyrom). Successful treatment of atopic diseases with allergoids tyrosin S and oralvac. Eur Respir J 2001; 16: Suppl. 31, 2896

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Allergen immunotherapy: therapeutic vaccines for allergic diseases
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=409
Year: 2003

Immunotherapy prevents the development of asthma in subjects with allergic rhinitis
Source: Eur Respir J 2001; 18: Suppl. 33, 482s
Year: 2001

Targeting atopic inflammation: anti-IgE treatment
Source: Annual Congress 2007 - Novel therapies for severe asthma
Year: 2007


Staphylococcal Enterotoxins sensitization and response of Omalizumab in severe atopic and non atopic asthma
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021


Specific immunotherapy in the management of allergic asthma
Source: Annual Congress 2008 - PG2 - Asthma: natural history, risk factors and overall management
Year: 2008



Efficacy of omalizumab in patients with concomitant allergic asthma and atopic dermatitis: a pilot study
Source: Annual Congress 2009 - Severe asthma and its treatment
Year: 2009


Specific allergen immunotherapy of asthma combined with allergic rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 441s
Year: 2006

Prevention of allergy and atopic diseases
Source: Annual Congress 2004 - Paediatric year in review
Year: 2004

Role of atopic dermatitis as a risk factor for allergic rhinitis in children
Source: Annual Congress 2010 - Paediatric epidemiology: asthma and associated factors
Year: 2010


Allergen-specific IgE patterns in allergic diseases of respiratory system with atopic dermatitis.
Source: International Congress 2019 – Asthma and allergies worldwide
Year: 2019


Treatment of co-morbid allergic asthma and perennial allergic rhinitis with the anti-IgE agent omalizumab
Source: Eur Respir J 2003; 22: Suppl. 45, 203s
Year: 2003

Probiotics in the treatment of atopic eczema in children
Source: Eur Respir J 2003; 22: Suppl. 45, 137s
Year: 2003

The specific methods of immunotherapy in treatment of the patients with allergic seasonal rhinitis
Source: Eur Respir J 2002; 20: Suppl. 38, 507s
Year: 2002

Efficacy of ruzam in the treatment of patients with perennial allergic rhinitis
Source: Eur Respir J 2004; 24: Suppl. 48, 131s
Year: 2004

Timing of solid food introduction in relation to atopic eczema and atopic sensitisation
Source: Eur Respir J 2005; 26: Suppl. 49, 395s
Year: 2005

Sublingual immunotherapy among patients, suffering from allergic rhinitis
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016

Omalizumab in severe adult atopic dermatitis associated to mild asthma treated with omalizumab
Source: Annual Congress 2012 - Asthma: assessment and treatment
Year: 2012

New method in treatment of atopic dermatitis – RUZAM preparation
Source: Eur Respir J 2004; 24: Suppl. 48, 590s
Year: 2004

Diagnosis and treatment of allergic rhinitis in asthmatic children
Source: Annual Congress 2009 - Allergic rhinitis and its impact on asthma in children
Year: 2009